| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 205.609 | 84 |
| GSM780708 | Untreated after 4 days (C2_1) | 208.941 | 84 |
| GSM780709 | Untreated after 4 days (C3_1) | 220.858 | 85 |
| GSM780719 | Untreated after 4 days (C1_2) | 200.321 | 84 |
| GSM780720 | Untreated after 4 days (C2_2) | 209.981 | 84 |
| GSM780721 | Untreated after 4 days (C3_2) | 212.064 | 84 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 493.64 | 91 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 230.06 | 85 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1034.17 | 96 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 395.577 | 90 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 207.989 | 84 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 933.199 | 95 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 224.522 | 85 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 372.74 | 89 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 297.995 | 87 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 201.093 | 84 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 358.457 | 89 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 285.953 | 87 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 247.675 | 86 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 302.607 | 87 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 232.432 | 85 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 237.871 | 85 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 251.726 | 86 |